{"gene":"CASP3","run_date":"2026-06-09T22:57:17","timeline":{"discoveries":[{"year":1994,"finding":"CPP32 (CASP3) encodes a 32-kDa cysteine protease; overexpression in Sf9 insect cells induces apoptosis, and co-expression of recombinant p20 and p11 subunits (derived from the full-length sequence) reconstitutes apoptotic activity, establishing that CPP32 is processed into a two-subunit active complex.","method":"Cloning, overexpression in Sf9 cells, co-expression of recombinant subunits","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstitution of active enzyme from recombinant subunits with functional (apoptotic) readout; foundational cloning paper replicated by multiple subsequent studies","pmids":["7983002"],"is_preprint":false},{"year":1995,"finding":"Purified Yama/CPP32 (CASP3) zymogen, when activated, cleaves PARP to generate the 85-kDa apoptotic fragment; this cleavage is inhibited by CrmA but not by an inactive CrmA point mutant, and CrmA blocks PARP cleavage in apoptotic cells.","method":"In vitro protease assay with purified recombinant protein, inhibitor mutagenesis (CrmA point mutant), cell-based PARP cleavage assay","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — purified enzyme assay with substrate cleavage, mutant inhibitor controls, replicated across labs","pmids":["7774019"],"is_preprint":false},{"year":1996,"finding":"The three-dimensional crystal structure of CPP32/apopain complexed with a tetrapeptide-aldehyde inhibitor was determined; the S4 subsite is strikingly different in size and chemical composition from ICE, explaining the distinct substrate specificity of CED-3-related versus ICE-related proteases.","method":"X-ray crystallography of inhibitor-bound complex","journal":"Nature structural biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure with functional interpretation of substrate-binding differences; single rigorous structural study","pmids":["8673606"],"is_preprint":false},{"year":1995,"finding":"Granzyme B, secreted by cytotoxic T lymphocytes, cleaves and activates the CPP32 precursor, providing a mechanistic link between CTL-mediated killing and activation of the CPP32/PARP cleavage pathway.","method":"In vitro cleavage assay: granzyme B incubated with CPP32 precursor; PARP cleavage as functional readout","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution of cleavage and activation; replicated independently by at least three additional groups (PMIDs 8700869, 8665848, 8702964)","pmids":["7566124","8700869","8665848","8702964"],"is_preprint":false},{"year":1996,"finding":"Granzyme B directly cleaves CPP32 between its large and small subunits, generating an active protease; the prodomain is then removed by an autocatalytic step (two-step mechanism). CrmA inhibits granzyme B-mediated CPP32 processing and apoptosis.","method":"Cell-free extract reconstitution, inhibitor studies (tetrapeptide CPP32 inhibitor vs. ICE inhibitor), CrmA co-expression","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — cell-free reconstitution plus inhibitor dissection; mechanistic details confirmed by independent groups","pmids":["8665848"],"is_preprint":false},{"year":1996,"finding":"Granzyme B directly activates purified Yama/CPP32 by limited proteolysis; activated Yama can bind inhibitors and cleave PARP. Processing of ICE by granzyme B does not activate ICE, demonstrating substrate selectivity.","method":"In vitro protease assay with purified proteins; PARP cleavage and inhibitor-binding as functional readouts","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — purified protein reconstitution with specificity controls (ICE vs. Yama); replicated","pmids":["8700869"],"is_preprint":false},{"year":1996,"finding":"Granzyme B from granzyme B-deficient mouse cytolytic cells fails to cleave and activate CPP32 and fails to induce DNA fragmentation in target cells, confirming a non-redundant role for granzyme B in CPP32 activation and downstream DNA fragmentation.","method":"Granzyme B knockout cells, peptide inhibitor of CPP32-like proteases, 51Cr release assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic loss-of-function (granzyme B KO) with specific functional readout; replicated concept","pmids":["8702964"],"is_preprint":false},{"year":1996,"finding":"CPP32/apopain cleaves U1-70 kDa snRNP protein and the catalytic subunit of DNA-dependent protein kinase (DNA-PKcs) at DEVD-like sites in vitro and in apoptotic cells, with fragments identical to those seen in intact apoptotic cells; cleavage is abolished by nanomolar Ac-DEVD-CHO.","method":"In vitro protease assay with purified apopain and isolated substrates; comparison of in vitro and in vivo cleavage fragments; inhibitor studies","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 1 / Strong — purified enzyme assay, fragment identity confirmed, inhibitor specificity; replicated independently","pmids":["8642305"],"is_preprint":false},{"year":1996,"finding":"CPP32 cleaves SREBP-1 and SREBP-2 at an aspartate residue during apoptosis, liberating transcriptionally active N-terminal fragments; an Asp→Ala mutation at the CPP32 cleavage site abolishes apoptosis-induced (but not sterol-regulated) SREBP cleavage.","method":"In vitro cleavage assay with purified CPP32; site-directed mutagenesis of the cleavage site; cell-based apoptosis assays (staurosporine, anti-Fas, etoposide)","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro enzyme assay plus site-directed mutagenesis of cleavage site confirming specificity","pmids":["8605870"],"is_preprint":false},{"year":1996,"finding":"CPP32 processes pro-Mch6 (caspase-9) and pro-Mch2alpha (caspase-6, the lamin-cleaving enzyme) in vitro, activating them; site-directed mutagenesis identified specific aspartate processing sites. Granzyme B activates CPP32 which then activates Mch2alpha, establishing a protease cascade: granzyme B → CPP32 → Mch2alpha/Mch6.","method":"In vitro protease assay with purified recombinant enzymes; site-directed mutagenesis of processing sites; co-incubation with cellular extracts","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution with mutagenesis; cascade demonstrated with purified components","pmids":["8900201"],"is_preprint":false},{"year":1996,"finding":"CPP32/apopain cleaves actin in vitro to 15- and 31-kDa fragments; a selective CPP32 inhibitor (Z-EVD-CH2-DCB) blocks actin cleavage and apoptosis in VP-16-treated U937 cells, and actin cleavage occurs in vivo during apoptosis.","method":"In vitro cleavage assay; antibody against cleavage-site neoepitope; selective caspase-3 inhibitor; cell-based apoptosis assay","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro enzyme assay plus neoepitope antibody confirming in vivo cleavage; inhibitor validation","pmids":["9070648"],"is_preprint":false},{"year":1996,"finding":"D4-GDI (a GDP dissociation inhibitor for Rho family GTPases) is cleaved by recombinant CPP32 in vitro at DELD19↓S; this cleavage also occurs in Jurkat cells undergoing Fas- or staurosporine-induced apoptosis and is blocked by DEVD-CHO but not by YVAD-CHO.","method":"In vitro cleavage assay with recombinant E. coli-expressed CPP32; N-terminal sequencing of cleavage fragment; cell-based inhibitor studies","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — purified enzyme cleavage with N-terminal sequencing of product; inhibitor specificity confirmed","pmids":["8626669"],"is_preprint":false},{"year":1996,"finding":"CPP32/Yama/apopain cleaves the catalytic subunit (p460) of DNA-PK in vitro, generating 230- and 160-kDa fragments and abolishing DNA-PK activity; cleavage is blocked by a selective CPP32 inhibitor but not by other protease inhibitors.","method":"In vitro cleavage assay with purified DNA-PK; kinase activity assay; selective inhibitor studies; cell-based apoptosis model","journal":"FEBS letters","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro enzyme assay with functional (kinase) readout; confirmed by independent group (PMID 8798786)","pmids":["8804412","8798786"],"is_preprint":false},{"year":1996,"finding":"Huntingtin is cleaved specifically by apopain (CPP32) in apoptotic extracts and by purified apopain; the rate of cleavage increases with polyglutamine tract length.","method":"In vitro cleavage assay with purified apopain and recombinant huntingtin variants; apoptotic cell extract cleavage assay","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution with substrate length variant series; mechanistically specific finding","pmids":["8696339"],"is_preprint":false},{"year":1996,"finding":"Fas-induced apoptosis sequentially activates ICE-like proteases followed by CPP32-like proteases; CPP32 activity accumulates in the cytosol in an ICE-dependent manner, and supplementing cell lysates from ICE-null thymocytes with recombinant CPP32 reconstitutes nuclear apoptosis.","method":"Cell-free apoptosis system; specific inhibitors of ICE- vs. CPP32-like proteases; ICE-null mouse thymocytes; recombinant CPP32 reconstitution","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 / Strong — genetic (ICE KO) and biochemical reconstitution with defined inhibitors; epistasis established","pmids":["8614469"],"is_preprint":false},{"year":1996,"finding":"An ICE-family protease (CAP/Mch2alpha homolog) purified from hamster cells cleaves and activates CPP32 in vitro; CAP activity is inhibited by CrmA and is itself activated by proteolytic cleavage, consistent with a cascade upstream of CPP32.","method":"Protein purification, in vitro CPP32 activation assay, protein sequencing, inhibitor studies","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — purified upstream activating protease identified by sequencing; in vitro activation of CPP32 reconstituted","pmids":["8662833"],"is_preprint":false},{"year":1996,"finding":"CPP32 proenzyme is proteolytically processed and activated in Fas-ligated Jurkat cells; CPP32 activation is blocked by cell-permeable inhibitors of aspartate-directed cysteine proteases and by overexpression of Bcl-2, placing Bcl-2 at or upstream of the CPP32 activation step.","method":"Western blot for CPP32 processing, cell-permeable inhibitors, Bcl-2 overexpression, cell viability assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — CPP32 processing monitored by Western blot; Bcl-2 overexpression epistasis; replicated by multiple groups","pmids":["8663439"],"is_preprint":false},{"year":1996,"finding":"Bcl-2 overexpression prevents CPP32 maturation (zymogen cleavage) and PARP cleavage in TNFα-induced apoptosis of U937 monocytes; no physical interaction between Bcl-2 and CPP32 was detected, indicating the inhibitory effect is indirect.","method":"Western blot for CPP32 processing; PARP cleavage assay; co-immunoprecipitation (negative result for physical interaction); Bcl-2 overexpression","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Western blot epistasis, negative Co-IP result mechanistically informative; single lab","pmids":["8619857"],"is_preprint":false},{"year":1996,"finding":"CPP32-like protease activity is activated in Fas-induced apoptosis of Jurkat T cells; the activity has kinetics similar to purified apopain, cleaves PARP, is recognized by anti-CPP32 antibodies but not anti-ICE antibodies, and a selective apopain inhibitor prevents Fas-induced apoptosis.","method":"Biochemical isolation of protease from apoptotic cells; kinetic analysis; substrate cleavage; antibody recognition; selective inhibitor","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal biochemical methods; replicated across labs","pmids":["8567626"],"is_preprint":false},{"year":1996,"finding":"CPP32 (caspase-3) cleaves p21-activated kinase gamma-PAK (Pak2) in vitro into two fragments (residues 1-212 and 213-524); subsequent autophosphorylation of both cleavage products occurs, and activation of the catalytic domain requires autophosphorylation at Thr-402 (mutation Thr402Ala abolishes activity).","method":"In vitro CPP32 cleavage assay with recombinant gamma-PAK; autophosphorylation assay; site-directed mutagenesis (Thr402Ala)","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution with mutagenesis; two-step activation mechanism defined","pmids":["9786869"],"is_preprint":false},{"year":1997,"finding":"The large subunit of DNA replication factor DSEB/RF-C140 is cleaved by caspase-3 at DEVD706/G during Fas-induced apoptosis in Jurkat cells; Asp706→Ala mutation abolishes cleavage in vitro; cleavage is inhibited by Ac-DEVD-CHO and iodoacetamide but not by CrmA or Ac-YVAD-CHO; recombinant caspase-3 (but not caspase-1) reproduces the in vivo cleavage.","method":"In vitro translated substrate cleavage assay; site-directed mutagenesis of cleavage site; selective caspase inhibitors; recombinant caspase-3 reconstitution","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — mutagenesis of cleavage site, reconstitution with pure enzyme, inhibitor specificity","pmids":["9235961"],"is_preprint":false},{"year":1996,"finding":"CPP32-deficient (knockout) mice display profoundly defective neuronal apoptosis during brain development, including absence of pyknotic clusters at morphogenetic sites and hyperplasias, establishing that CPP32 is essential for morphogenetic cell death in the mammalian brain in vivo.","method":"Homologous recombination knockout; histological analysis; embryonic brain phenotyping","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — germline KO with specific developmental phenotype; foundational loss-of-function study replicated by independent group (PMID 9512515)","pmids":["8934524","9512515"],"is_preprint":false},{"year":1998,"finding":"CPP32 (caspase-3) is required for chromatin condensation and DNA degradation in certain apoptotic cell types, but other hallmarks of apoptosis can proceed in its absence; the requirement is stimulus- and tissue-specific (e.g., required for UV- but not γ-irradiation-induced apoptosis in ES cells; required for TNFα-induced apoptosis in transformed MEFs but not thymocytes).","method":"Comprehensive analysis of CPP32-deficient mice, ES cells, and MEFs with multiple apoptotic stimuli; DNA fragmentation, chromatin condensation assays","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal cell types and stimuli in KO background; systematic loss-of-function study","pmids":["9512515"],"is_preprint":false},{"year":1996,"finding":"C. elegans CED-3 cysteine protease has substrate specificity similar to CPP32 (both prefer DEVD-like sites), distinct from ICE or NEDD2/ICH-1, supporting CPP32 as the mammalian functional equivalent of CED-3.","method":"Purification of CED-3 and four ICE-family proteases; direct comparative substrate specificity assays","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 1 / Strong — purified enzymes compared with defined substrates; ortholog relationship established biochemically","pmids":["8654923"],"is_preprint":false},{"year":1997,"finding":"Active CPP32 (caspase-3) is the major active caspase in apoptotic tumor cells across multiple stimuli and cell lines; CPP32 is present as multiple active species whose pattern varies between cell lines but is constant across stimuli within a given line, indicating cell-line-specific processing differences.","method":"Novel active-caspase detection approach (affinity labeling); multiple tumor cell lines and apoptotic stimuli; CPP32 and Mch2 identified simultaneously","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — active-site labeling across multiple cell lines and stimuli; systematic identification of major active caspase species","pmids":["9171342"],"is_preprint":false},{"year":1997,"finding":"CPP32 activation during Fas-induced apoptosis requires macromolecular synthesis and upstream CED3/ICE protease activity; affinity labeling of the active-site cysteine identified p20/p18 processed subunits in apoptotic but not necrotic granule neurons, with CPP32 activation preceding PARP cleavage and DNA laddering.","method":"Active-site affinity labeling; RNA and protein synthesis inhibitors; CED3/ICE inhibitor pretreatment; temporal Western blot analysis","journal":"The Journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — active-site labeling plus inhibitor epistasis; single lab but multiple orthogonal methods","pmids":["8987778"],"is_preprint":false},{"year":1997,"finding":"Fas-induced activation of JNK/SAPK (via MKK7) and p38 (via MKK6), cell shrinkage, surface blebbing, Apo2.7 antigen induction, and cell death all occur independently of CPP32-like protease activity; CPP32-like proteases are specifically required for chromatin condensation and DNA fragmentation but not for other Fas-induced apoptotic events.","method":"Selective caspase inhibitors (DEVD-type vs. VAD-type) in Jurkat and KB cells; kinase activation assays; morphological and cell death assessments","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — pharmacological epistasis with highly selective inhibitors; multiple orthogonal readouts; clearly defined pathway bifurcation","pmids":["9362518"],"is_preprint":false},{"year":1998,"finding":"During T-cell negative selection in vivo, CPP32 activation (detected by proteolytic cleavage of p32 zymogen) occurs specifically upon anti-CD3 crosslinking or antigen challenge (pigeon cytochrome C in MHC-compatible mice) and precedes phosphatidylserine exposure; it is not detected during spontaneous thymocyte apoptosis, suggesting a distinct pathway for activation-induced cell death.","method":"Western blot for CPP32 processing; PARP cleavage; in vivo antigen challenge of TCR-transgenic mice; caspase inhibitor (zVAD) studies","journal":"The Journal of experimental medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo antigen challenge with transgenic mice plus biochemical readouts; single lab","pmids":["9348308"],"is_preprint":false},{"year":1997,"finding":"Thyroid hormone up-regulates Xenopus CPP32/apopain/Yama gene expression in a tadpole tail myoblast cell line (XLT-15), and a CPP32/apopain inhibitor (Ac-DEVD-CHO) prevents thyroid hormone-induced apoptosis, while an ICE inhibitor does not, establishing that CPP32 mediates thyroid hormone-dependent apoptosis in this model.","method":"RT-PCR for CPP32 mRNA; TUNEL assay; selective inhibitor (DEVD-CHO vs. YVAD-CHO); cell viability","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — selective inhibitor dissects CPP32 vs. ICE; single lab with two orthogonal readouts (mRNA induction + inhibitor rescue)","pmids":["9030578"],"is_preprint":false},{"year":1998,"finding":"MST1 kinase activates JNK which in turn activates caspase-3 (Casp3) in a signaling cascade mediating neuronal apoptosis in high-fat diet mouse brain and HT22 cells; shRNA knockdown of MST1 significantly reduces JNK/Casp3 signaling.","method":"Western blot; immunofluorescence; shRNA knockdown of MST1; in vivo HFD mouse model","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function (shRNA) with Western blot confirmation; in vivo and in vitro; single lab","pmids":["31117242"],"is_preprint":false},{"year":1999,"finding":"Caspase-2 (Nedd-2) processing and cell death in trophic factor-deprived PC12 cells and sympathetic neurons occur independently of caspase-3 (CPP32)-like activity; DEVD-FMK inhibits caspase-3-like activity but does not suppress caspase-2 processing or cell death; caspase-3-like activity is neither necessary nor sufficient for death in this paradigm.","method":"Selective caspase inhibitors (DEVD-FMK vs. BAF/zVAD-FMK); caspase-2 antisense oligonucleotide; Western blot for caspase-2 processing; cell survival assays","journal":"The Journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — inhibitor and antisense epistasis; single lab; finding is a negative result for CPP32 requirement that is itself mechanistically informative","pmids":["9801360"],"is_preprint":false},{"year":2020,"finding":"Ursolic acid (UA) metabolite irreversibly inhibits CASP3 by forming a covalent bond with Cys-163 of caspase-3 via an epoxy group; an alkynyl-modified UA probe captured CASP3 as the primary target from mouse liver, and binding was verified by molecular docking, biochemical evaluation in HepG2 cells, and in vivo liver injury attenuation.","method":"Chemical probe (alkynyl-modified UA) pulldown/proteome identification; molecular docking to active-site Cys-163; biochemical CASP3 activity assay; in vivo alcoholic liver disease model","journal":"Acta pharmacologica Sinica","confidence":"Medium","confidence_rationale":"Tier 1-2 / Moderate — chemical probe target identification plus docking and biochemical validation; single lab with multiple orthogonal methods","pmids":["33028983"],"is_preprint":false},{"year":2017,"finding":"HOXC13 represses transcription of CASP3 by directly binding to the CASP3 promoter region (ChIP analysis); knockdown of HOXC13 in esophageal squamous cell carcinoma cells upregulates CASP3 and induces apoptosis.","method":"ChIP analysis; HOXC13 knockdown; RT-PCR and Western blot for CASP3; apoptosis assay","journal":"Cancer science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP establishes direct promoter binding; loss-of-function with functional readout; single lab","pmids":["29168599"],"is_preprint":false}],"current_model":"CASP3/CPP32 (caspase-3) is synthesized as a 32-kDa inactive zymogen that is proteolytically activated by upstream ICE-family proteases or by granzyme B (which cleaves between the large and small subunits, followed by autocatalytic prodomain removal) to yield an active p20/p11 heterodimeric cysteine protease; the activated enzyme cleaves a defined set of substrates at DEVD-like sites—including PARP, DNA-PKcs, DSEB/RF-C140, SREBPs, huntingtin, D4-GDI, actin, lamin-associated Mch2alpha, and Pak2—to dismantle nuclear repair, DNA replication, cytoskeletal, and signaling functions; its S4 substrate-binding pocket is structurally distinct from ICE, conferring DEVD specificity; Bcl-2/Bcl-xL act upstream to prevent CPP32 activation without direct physical interaction; CPP32 is essential for chromatin condensation, DNA fragmentation, and morphogenetic brain apoptosis in vivo, but other apoptotic events (JNK/p38 activation, membrane blebbing, cell death itself) can proceed independently of CPP32-like activity in certain contexts."},"narrative":{"mechanistic_narrative":"CASP3 (CPP32/Yama/apopain) is the principal executioner cysteine protease of apoptosis, synthesized as a 32-kDa zymogen that is proteolytically processed into a two-subunit (p20/p11) active enzyme [PMID:7983002]. Its crystal structure bound to a tetrapeptide-aldehyde inhibitor revealed an S4 subsite distinct from ICE, accounting for its preference for DEVD-like cleavage sites [PMID:8673606], a specificity that mirrors C. elegans CED-3 and marks CASP3 as the mammalian functional equivalent of that death protease [PMID:8654923]. CASP3 is activated by limited proteolysis at the junction between its large and small subunits, either by cytotoxic-lymphocyte granzyme B followed by autocatalytic prodomain removal [PMID:7566124, PMID:8700869, PMID:8665848, PMID:8702964] or by upstream ICE/CED3-family proteases, placing it downstream in a sequential caspase cascade during Fas-induced death [PMID:8614469, PMID:8662833]. Once active, CASP3 cleaves a defined substrate set at DEVD-like sites to dismantle the cell: PARP [PMID:7774019], the DNA-PKcs catalytic subunit [PMID:8642305, PMID:8804412, PMID:8798786], DNA replication factor DSEB/RF-C140 [PMID:9235961], U1-70K snRNP [PMID:8642305], SREBP-1/2 [PMID:8605870], huntingtin [PMID:8696339], the Rho-GTPase regulator D4-GDI [PMID:8626669], actin [PMID:9070648], and the kinase Pak2 [PMID:9786869]; it also amplifies the cascade by processing and activating pro-caspase-9 (Mch6) and the lamin-cleaving caspase-6 (Mch2alpha) [PMID:8900201]. CASP3 is itself held in check upstream by Bcl-2, which blocks zymogen maturation without physically binding the enzyme [PMID:8663439, PMID:8619857]. Genetic ablation establishes that CASP3 is essential for morphogenetic neuronal apoptosis in the developing brain [PMID:8934524, PMID:9512515] and for chromatin condensation and DNA fragmentation, although membrane blebbing, JNK/p38 activation and cell death itself can proceed independently of CASP3 activity in a stimulus- and tissue-specific manner [PMID:9512515, PMID:9362518].","teleology":[{"year":1994,"claim":"Established the molecular identity of CASP3 as a 32-kDa cysteine protease whose proteolytic processing into two subunits is required for pro-apoptotic activity.","evidence":"Cloning and Sf9 overexpression with reconstitution from recombinant p20/p11 subunits","pmids":["7983002"],"confidence":"High","gaps":["Did not identify the physiological protease(s) that perform the activating cleavage","No substrate repertoire defined at this stage"]},{"year":1995,"claim":"Defined the first executioner function by showing CASP3 cleaves PARP to its apoptotic signature fragment, linking the protease to a specific nuclear substrate.","evidence":"In vitro protease assay with purified enzyme; CrmA wild-type vs. inactive mutant controls; cell-based PARP cleavage","pmids":["7774019"],"confidence":"High","gaps":["Did not establish whether PARP cleavage is causal for death or a bystander event","Upstream activator still unknown"]},{"year":1995,"claim":"Identified granzyme B as a physiological activator, connecting CTL-mediated killing to the CASP3/PARP pathway.","evidence":"In vitro cleavage of CPP32 precursor by granzyme B with PARP cleavage readout; independently replicated","pmids":["7566124","8700869","8665848","8702964"],"confidence":"High","gaps":["Granzyme-independent activation routes not yet defined here"]},{"year":1996,"claim":"Resolved the activation mechanism and its specificity: granzyme B cleaves between large and small subunits followed by autocatalytic prodomain removal, and does not activate ICE.","evidence":"Cell-free reconstitution, purified-protein cleavage, inhibitor dissection (CPP32 vs. ICE inhibitors), CrmA; KO granzyme B cells confirm non-redundancy","pmids":["8665848","8700869","8702964"],"confidence":"High","gaps":["Structural basis of subunit-junction recognition by granzyme B not defined","Relative contribution of autocatalysis vs. trans-cleavage in cells unquantified"]},{"year":1996,"claim":"Provided the structural explanation for DEVD specificity, distinguishing CED-3-like from ICE-like proteases.","evidence":"X-ray crystallography of inhibitor-bound CPP32/apopain; comparative analysis of the S4 subsite","pmids":["8673606"],"confidence":"High","gaps":["No structure of the apo or fully zymogenic form","Does not capture substrate-induced conformational changes"]},{"year":1996,"claim":"Placed CASP3 within a sequential protease cascade downstream of ICE-like enzymes and showed it both receives and propagates activation.","evidence":"Cell-free Fas system, ICE-null thymocyte reconstitution with recombinant CASP3, purified upstream activating protease (CAP/Mch2alpha homolog); CASP3 activation of pro-caspase-9 and caspase-6","pmids":["8614469","8662833","8900201"],"confidence":"High","gaps":["The full set of physiological upstream initiators was not enumerated","Quantitative hierarchy of cascade branches in vivo unresolved"]},{"year":1996,"claim":"Mapped a broad DEVD-site substrate repertoire, explaining how CASP3 dismantles nuclear, replication, cytoskeletal, and signaling machinery.","evidence":"In vitro cleavage of DNA-PKcs, U1-70K, SREBP-1/2, huntingtin, D4-GDI, actin (with neoepitope antibodies, N-terminal sequencing, cleavage-site mutagenesis) plus matched in vivo apoptotic fragments and inhibitor specificity","pmids":["8642305","8804412","8798786","8605870","8696339","8626669","9070648"],"confidence":"High","gaps":["Did not establish which cleavages are necessary vs. dispensable for the death phenotype","Order and kinetics of substrate processing in cells not fully ordered"]},{"year":1996,"claim":"Positioned Bcl-2 as an upstream, indirect inhibitor acting at the CASP3 maturation step rather than by binding the protease.","evidence":"Western blot for zymogen processing under Bcl-2 overexpression; negative co-immunoprecipitation for physical interaction","pmids":["8663439","8619857"],"confidence":"Medium","gaps":["Negative Co-IP does not define the actual molecular intermediary blocked by Bcl-2","Single-lab for the indirect-mechanism conclusion"]},{"year":1996,"claim":"Established CASP3 as the major active executioner caspase across diverse apoptotic stimuli, with cell-line-specific processed species.","evidence":"Active-site affinity labeling across multiple tumor lines and stimuli","pmids":["9171342"],"confidence":"High","gaps":["Functional meaning of distinct processed species between lines not resolved"]},{"year":1996,"claim":"Demonstrated in vivo non-redundancy: CASP3 is essential for morphogenetic neuronal apoptosis in the developing brain.","evidence":"Germline knockout mice with histological brain phenotyping; independently replicated","pmids":["8934524","9512515"],"confidence":"High","gaps":["Tissue-specific substrate dependencies underlying the brain phenotype not dissected"]},{"year":1998,"claim":"Delimited CASP3's functional scope: required for chromatin condensation and DNA fragmentation but dispensable for other apoptotic hallmarks, in a stimulus- and tissue-specific manner.","evidence":"Comprehensive KO mouse/ES cell/MEF analysis with multiple stimuli; selective DEVD vs. VAD inhibitor epistasis with morphological and kinase readouts","pmids":["9512515","9362518"],"confidence":"High","gaps":["Identity of the redundant caspases substituting in CASP3-null cells not established here","Mechanism of stimulus-specific requirement unresolved"]},{"year":1999,"claim":"Refined pathway boundaries by showing CASP3-like activity is neither necessary nor sufficient for death in trophic-factor-deprived neurons, where caspase-2 acts independently.","evidence":"Selective inhibitor (DEVD-FMK vs. BAF) and caspase-2 antisense epistasis in PC12 cells and sympathetic neurons","pmids":["9801360"],"confidence":"Medium","gaps":["Single-lab pharmacological/antisense dissection","Does not exclude partial CASP3 contribution masked by redundancy"]},{"year":2019,"claim":"Added an upstream signaling input by placing CASP3 downstream of an MST1→JNK cascade in diet-associated neuronal apoptosis.","evidence":"shRNA knockdown of MST1 with Western/immunofluorescence in HFD mouse brain and HT22 cells","pmids":["31117242"],"confidence":"Medium","gaps":["Single-lab correlational signaling pathway","Direct vs. indirect link between JNK and CASP3 activation not biochemically resolved"]},{"year":2020,"claim":"Defined a pharmacological handle on the active-site cysteine, identifying CASP3 Cys-163 as a covalent target for an irreversible small-molecule inhibitor.","evidence":"Alkynyl-modified ursolic acid probe pulldown/proteome ID, molecular docking to Cys-163, biochemical activity assay, in vivo liver injury model","pmids":["33028983"],"confidence":"Medium","gaps":["Selectivity versus other caspases not fully quantified","Single-lab target identification"]},{"year":2017,"claim":"Identified transcriptional regulation of CASP3 by HOXC13 as a route controlling apoptotic threshold in cancer cells.","evidence":"ChIP showing direct promoter binding; HOXC13 knockdown with CASP3 induction and apoptosis readout in esophageal squamous carcinoma cells","pmids":["29168599"],"confidence":"Medium","gaps":["Single-lab; generality across tissues unknown","Does not link transcriptional control to specific physiological death programs"]},{"year":null,"claim":"How CASP3 substrate cleavage choices are prioritized in vivo and which cleavages are causally required for the death phenotype versus tissue-redundant remains unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No systematic mapping of which substrate cleavages are necessary vs. dispensable for death","Identity of caspases redundant with CASP3 in null tissues not defined in this corpus","Structural basis of zymogen-to-active transition not captured"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,1,7,8,9,10,11,12,13,19,20]},{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[0,1,2]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[14]}],"pathway":[{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[0,21,22,26]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[3,6,27]}],"complexes":[],"partners":["GZMB","BCL2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P42574","full_name":"Caspase-3","aliases":["Apopain","Cysteine protease CPP32","CPP-32","Protein Yama","SREBP cleavage activity 1","SCA-1"],"length_aa":277,"mass_kda":31.6,"function":"Thiol protease that acts as a major effector caspase involved in the execution phase of apoptosis (PubMed:18723680, PubMed:20566630, PubMed:23650375, PubMed:35338844, PubMed:35446120, PubMed:7596430). Following cleavage and activation by initiator caspases (CASP8, CASP9 and/or CASP10), mediates execution of apoptosis by catalyzing cleavage of many proteins (PubMed:18723680, PubMed:20566630, PubMed:23650375, PubMed:7596430). At the onset of apoptosis, it proteolytically cleaves poly(ADP-ribose) polymerase PARP1 at a '216-Asp-|-Gly-217' bond (PubMed:10497198, PubMed:16374543, PubMed:7596430, PubMed:7774019). Cleaves and activates sterol regulatory element binding proteins (SREBPs) between the basic helix-loop-helix leucine zipper domain and the membrane attachment domain (By similarity). Cleaves and activates caspase-6, -7 and -9 (CASP6, CASP7 and CASP9, respectively) (PubMed:7596430). Cleaves and inactivates interleukin-18 (IL18) (PubMed:37993714, PubMed:9334240). Involved in the cleavage of huntingtin (PubMed:8696339). Triggers cell adhesion in sympathetic neurons through RET cleavage (PubMed:21357690). Cleaves DSG2 in response to apoptosis resulting in a loss of full length DSG2 at desmosome cell junctions and subsequent loss of cell-cell adhesion (PubMed:17559062). Also cleaves JUP in response to apoptosis (PubMed:17559062). Cleaves and inhibits serine/threonine-protein kinase AKT1 in response to oxidative stress (PubMed:23152800). Acts as an inhibitor of type I interferon production during virus-induced apoptosis by mediating cleavage of antiviral proteins CGAS, IRF3 and MAVS, thereby preventing cytokine overproduction (PubMed:30878284). Also involved in pyroptosis by mediating cleavage and activation of gasdermin-E (GSDME) (PubMed:35338844, PubMed:35446120). Cleaves XRCC4 and phospholipid scramblase proteins XKR4, XKR8 and XKR9, leading to promote phosphatidylserine exposure on apoptotic cell surface (PubMed:23845944, PubMed:33725486). Cleaves BIRC6 following inhibition of BIRC6-caspase binding by DIABLO/SMAC (PubMed:36758104, PubMed:36758106)","subcellular_location":"Cytoplasm","url":"https://www.uniprot.org/uniprotkb/P42574/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CASP3","classification":"Not Classified","n_dependent_lines":3,"n_total_lines":1208,"dependency_fraction":0.0024834437086092716},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000164305","cell_line_id":"CID001706","localizations":[{"compartment":"cytoplasmic","grade":3},{"compartment":"nucleoplasm","grade":2}],"interactors":[{"gene":"EIF4E","stoichiometry":0.2},{"gene":"PDPK1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID001706","total_profiled":1310},"omim":[{"mim_id":"621436","title":"MICROCEPHALY, PROGRESSIVE, WITH SIMPLIFIED GYRAL PATTERN AND CEREBELLAR HYPOPLASIA; MGCH","url":"https://www.omim.org/entry/621436"},{"mim_id":"621370","title":"X KELL BLOOD GROUP PRECURSOR-RELATED FAMILY, MEMBER 9; XKR9","url":"https://www.omim.org/entry/621370"},{"mim_id":"621368","title":"X KELL BLOOD GROUP PRECURSOR-RELATED FAMILY, MEMBER 4; XKR4","url":"https://www.omim.org/entry/621368"},{"mim_id":"620974","title":"ZINC FINGER PROTEIN 862; ZNF862","url":"https://www.omim.org/entry/620974"},{"mim_id":"620924","title":"NOTCHLESS HOMOLOG 1; NLE1","url":"https://www.omim.org/entry/620924"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Mitochondria","reliability":"Approved"},{"location":"Nucleoplasm","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/CASP3"},"hgnc":{"alias_symbol":["CPP32","CPP32B","Yama","apopain"],"prev_symbol":[]},"alphafold":{"accession":"P42574","domains":[{"cath_id":"3.40.50.1460","chopping":"42-167_188-212_263-267","consensus_level":"high","plddt":95.6792,"start":42,"end":267}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P42574","model_url":"https://alphafold.ebi.ac.uk/files/AF-P42574-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P42574-F1-predicted_aligned_error_v6.png","plddt_mean":85.81},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CASP3","jax_strain_url":"https://www.jax.org/strain/search?query=CASP3"},"sequence":{"accession":"P42574","fasta_url":"https://rest.uniprot.org/uniprotkb/P42574.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P42574/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P42574"}},"corpus_meta":[{"pmid":"7774019","id":"PMC_7774019","title":"Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase.","date":"1995","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/7774019","citation_count":2332,"is_preprint":false},{"pmid":"8934524","id":"PMC_8934524","title":"Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice.","date":"1996","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/8934524","citation_count":1635,"is_preprint":false},{"pmid":"7983002","id":"PMC_7983002","title":"CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme.","date":"1994","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7983002","citation_count":1084,"is_preprint":false},{"pmid":"8614469","id":"PMC_8614469","title":"Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis.","date":"1996","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/8614469","citation_count":939,"is_preprint":false},{"pmid":"9512515","id":"PMC_9512515","title":"Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes.","date":"1998","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/9512515","citation_count":740,"is_preprint":false},{"pmid":"7566124","id":"PMC_7566124","title":"Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B.","date":"1995","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/7566124","citation_count":635,"is_preprint":false},{"pmid":"8642305","id":"PMC_8642305","title":"Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death.","date":"1996","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/8642305","citation_count":549,"is_preprint":false},{"pmid":"9295387","id":"PMC_9295387","title":"Activation of CPP32-like caspases contributes to neuronal apoptosis and neurological dysfunction after traumatic brain injury.","date":"1997","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/9295387","citation_count":497,"is_preprint":false},{"pmid":"8696339","id":"PMC_8696339","title":"Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract.","date":"1996","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8696339","citation_count":482,"is_preprint":false},{"pmid":"8567626","id":"PMC_8567626","title":"CPP32/apopain is a key interleukin 1 beta converting enzyme-like protease involved in Fas-mediated apoptosis.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8567626","citation_count":471,"is_preprint":false},{"pmid":"9108467","id":"PMC_9108467","title":"Immunohistochemical analysis of in vivo patterns of expression of CPP32 (Caspase-3), a cell death protease.","date":"1997","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/9108467","citation_count":393,"is_preprint":false},{"pmid":"8673606","id":"PMC_8673606","title":"The three-dimensional structure of apopain/CPP32, a key mediator of apoptosis.","date":"1996","source":"Nature structural biology","url":"https://pubmed.ncbi.nlm.nih.gov/8673606","citation_count":366,"is_preprint":false},{"pmid":"9171342","id":"PMC_9171342","title":"Multiple species of CPP32 and Mch2 are the major active caspases present in apoptotic cells.","date":"1997","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/9171342","citation_count":328,"is_preprint":false},{"pmid":"8663439","id":"PMC_8663439","title":"Fas-induced activation of the cell death-related protease CPP32 Is inhibited by Bcl-2 and by ICE family protease inhibitors.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8663439","citation_count":305,"is_preprint":false},{"pmid":"8654923","id":"PMC_8654923","title":"The Caenorhabditis elegans cell-death protein CED-3 is a cysteine protease with substrate specificities similar to those of the human CPP32 protease.","date":"1996","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/8654923","citation_count":287,"is_preprint":false},{"pmid":"8605870","id":"PMC_8605870","title":"Cleavage of sterol regulatory element binding proteins (SREBPs) by CPP32 during apoptosis.","date":"1996","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/8605870","citation_count":283,"is_preprint":false},{"pmid":"8900201","id":"PMC_8900201","title":"The Ced-3/interleukin 1beta converting enzyme-like homolog Mch6 and the lamin-cleaving enzyme Mch2alpha are substrates for the apoptotic mediator CPP32.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8900201","citation_count":269,"is_preprint":false},{"pmid":"9531309","id":"PMC_9531309","title":"Activation of caspase 3 (CPP32)-like proteases is essential for TNF-alpha-induced hepatic parenchymal cell apoptosis and neutrophil-mediated necrosis in a murine endotoxin shock model.","date":"1998","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/9531309","citation_count":262,"is_preprint":false},{"pmid":"8987778","id":"PMC_8987778","title":"Activation of the CED3/ICE-related protease CPP32 in cerebellar granule neurons undergoing apoptosis but not necrosis.","date":"1997","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/8987778","citation_count":259,"is_preprint":false},{"pmid":"8665848","id":"PMC_8665848","title":"The cytotoxic cell protease granzyme B initiates apoptosis in a cell-free system by proteolytic processing and activation of the ICE/CED-3 family protease, CPP32, via a novel two-step mechanism.","date":"1996","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/8665848","citation_count":251,"is_preprint":false},{"pmid":"9070648","id":"PMC_9070648","title":"Actin cleavage by CPP-32/apopain during the development of apoptosis.","date":"1997","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/9070648","citation_count":220,"is_preprint":false},{"pmid":"10526349","id":"PMC_10526349","title":"Processing and analysis of CASP3 protein structure predictions.","date":"1999","source":"Proteins","url":"https://pubmed.ncbi.nlm.nih.gov/10526349","citation_count":220,"is_preprint":false},{"pmid":"8626669","id":"PMC_8626669","title":"D4-GDI, a substrate of CPP32, is proteolyzed during Fas-induced apoptosis.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8626669","citation_count":206,"is_preprint":false},{"pmid":"8567622","id":"PMC_8567622","title":"Identification and characterization of CPP32/Mch2 homolog 1, a novel cysteine protease similar to CPP32.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8567622","citation_count":188,"is_preprint":false},{"pmid":"8620480","id":"PMC_8620480","title":"Involvement of CPP32/Yama(-like) proteases in Fas-mediated apoptosis.","date":"1996","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/8620480","citation_count":171,"is_preprint":false},{"pmid":"8700869","id":"PMC_8700869","title":"Proteolytic activation of the cell death protease Yama/CPP32 by granzyme B.","date":"1996","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8700869","citation_count":167,"is_preprint":false},{"pmid":"8822910","id":"PMC_8822910","title":"Activation of the CPP32 protease in apoptosis induced by 1-beta-D-arabinofuranosylcytosine and other DNA-damaging agents.","date":"1996","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/8822910","citation_count":166,"is_preprint":false},{"pmid":"8840993","id":"PMC_8840993","title":"Overexpression of Bcl-2 or Bcl-xL inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells.","date":"1996","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/8840993","citation_count":152,"is_preprint":false},{"pmid":"8663611","id":"PMC_8663611","title":"Activation of the CPP32 apoptotic protease by distinct signaling pathways with differential sensitivity to Bcl-xL.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8663611","citation_count":152,"is_preprint":false},{"pmid":"8637709","id":"PMC_8637709","title":"Bcl-2 and adenovirus E1B 19 kDA protein prevent E1A-induced processing of CPP32 and cleavage of poly(ADP-ribose) polymerase.","date":"1996","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/8637709","citation_count":144,"is_preprint":false},{"pmid":"8940042","id":"PMC_8940042","title":"Induction of CPP32-like activity in PC12 cells by withdrawal of trophic support. Dissociation from apoptosis.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8940042","citation_count":143,"is_preprint":false},{"pmid":"9130145","id":"PMC_9130145","title":"Activation of CPP32 during apoptosis of neurons and astrocytes.","date":"1997","source":"Journal of neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/9130145","citation_count":141,"is_preprint":false},{"pmid":"9226163","id":"PMC_9226163","title":"The roles of Bcl-X(L) and apopain in the control of erythropoiesis by erythropoietin.","date":"1997","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/9226163","citation_count":136,"is_preprint":false},{"pmid":"9362518","id":"PMC_9362518","title":"Fas induces cytoplasmic apoptotic responses and activation of the MKK7-JNK/SAPK and MKK6-p38 pathways independent of CPP32-like proteases.","date":"1997","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/9362518","citation_count":136,"is_preprint":false},{"pmid":"8702964","id":"PMC_8702964","title":"Cleavage of CPP32 by granzyme B represents a critical role for granzyme B in the induction of target cell DNA fragmentation.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8702964","citation_count":128,"is_preprint":false},{"pmid":"20423928","id":"PMC_20423928","title":"Common variants in CASP3 confer susceptibility to Kawasaki disease.","date":"2010","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20423928","citation_count":124,"is_preprint":false},{"pmid":"9864397","id":"PMC_9864397","title":"Alteration of caspase-3 (CPP32/Yama/apopain) in wild-type MCF-7, breast cancer cells.","date":"1999","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/9864397","citation_count":120,"is_preprint":false},{"pmid":"8798786","id":"PMC_8798786","title":"DNA-dependent protein kinase is a target for a CPP32-like apoptotic protease.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8798786","citation_count":119,"is_preprint":false},{"pmid":"9377572","id":"PMC_9377572","title":"High levels of expression and nuclear localization of interleukin-1 beta converting enzyme (ICE) and CPP32 in favorable human neuroblastomas.","date":"1997","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/9377572","citation_count":116,"is_preprint":false},{"pmid":"9786869","id":"PMC_9786869","title":"Cleavage and activation of p21-activated protein kinase gamma-PAK by CPP32 (caspase 3). Effects of autophosphorylation on activity.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9786869","citation_count":112,"is_preprint":false},{"pmid":"9801360","id":"PMC_9801360","title":"Caspase-2 (Nedd-2) processing and death of trophic factor-deprived PC12 cells and sympathetic neurons occur independently of caspase-3 (CPP32)-like activity.","date":"1998","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/9801360","citation_count":95,"is_preprint":false},{"pmid":"9166725","id":"PMC_9166725","title":"Characterization of CPP32-like protease activity following apoptotic challenge in SH-SY5Y neuroblastoma cells.","date":"1997","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9166725","citation_count":94,"is_preprint":false},{"pmid":"15127291","id":"PMC_15127291","title":"Somatic mutations of CASP3 gene in human cancers.","date":"2004","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15127291","citation_count":92,"is_preprint":false},{"pmid":"21987091","id":"PMC_21987091","title":"ITPKC and CASP3 polymorphisms and risks for IVIG unresponsiveness and coronary artery lesion formation in Kawasaki disease.","date":"2011","source":"The pharmacogenomics journal","url":"https://pubmed.ncbi.nlm.nih.gov/21987091","citation_count":92,"is_preprint":false},{"pmid":"9030578","id":"PMC_9030578","title":"Induction of apoptosis and CPP32 expression by thyroid hormone in a myoblastic cell line derived from tadpole tail.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9030578","citation_count":91,"is_preprint":false},{"pmid":"9927052","id":"PMC_9927052","title":"Activation of c-Jun NH2-terminal kinase and subsequent CPP32/Yama during topoisomerase inhibitor beta-lapachone-induced apoptosis through an oxidation-dependent pathway.","date":"1999","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/9927052","citation_count":86,"is_preprint":false},{"pmid":"8662833","id":"PMC_8662833","title":"Purification and characterization of an interleukin-1beta-converting enzyme family protease that activates cysteine protease P32 (CPP32).","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8662833","citation_count":86,"is_preprint":false},{"pmid":"10092794","id":"PMC_10092794","title":"Overexpression of protein kinase C isoforms protects RAW 264.7 macrophages from nitric oxide-induced apoptosis: involvement of c-Jun N-terminal kinase/stress-activated protein kinase, p38 kinase, and CPP-32 protease pathways.","date":"1999","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/10092794","citation_count":86,"is_preprint":false},{"pmid":"9160689","id":"PMC_9160689","title":"Immunolocalization of the ICE/Ced-3-family protease, CPP32 (Caspase-3), in non-Hodgkin's lymphomas, chronic lymphocytic leukemias, and reactive lymph nodes.","date":"1997","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/9160689","citation_count":86,"is_preprint":false},{"pmid":"8853905","id":"PMC_8853905","title":"Bcl-xL overexpression inhibits taxol-induced Yama protease activity and apoptosis.","date":"1996","source":"Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/8853905","citation_count":84,"is_preprint":false},{"pmid":"10361096","id":"PMC_10361096","title":"Progress in protein structure prediction: assessment of CASP3.","date":"1999","source":"Current opinion in structural biology","url":"https://pubmed.ncbi.nlm.nih.gov/10361096","citation_count":80,"is_preprint":false},{"pmid":"9185777","id":"PMC_9185777","title":"Processing/activation of CPP32-like proteases is involved in transforming growth factor beta1-induced apoptosis in rat hepatocytes.","date":"1997","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/9185777","citation_count":78,"is_preprint":false},{"pmid":"25400823","id":"PMC_25400823","title":"MiR-378 overexpression attenuates high glucose-suppressed osteogenic differentiation through targeting CASP3 and activating PI3K/Akt signaling pathway.","date":"2014","source":"International journal of clinical and experimental pathology","url":"https://pubmed.ncbi.nlm.nih.gov/25400823","citation_count":73,"is_preprint":false},{"pmid":"9891491","id":"PMC_9891491","title":"Immunohistochemistry of Caspase3/CPP32 in human stomach and its correlation with cell proliferation and apoptosis.","date":"1998","source":"Anticancer research","url":"https://pubmed.ncbi.nlm.nih.gov/9891491","citation_count":73,"is_preprint":false},{"pmid":"9168807","id":"PMC_9168807","title":"Intact cell evidence for the early synthesis, and subsequent late apopain-mediated suppression, of poly(ADP-ribose) during apoptosis.","date":"1997","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/9168807","citation_count":72,"is_preprint":false},{"pmid":"9348308","id":"PMC_9348308","title":"Specific activation of the cysteine protease CPP32 during the negative selection of T cells in the thymus.","date":"1997","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/9348308","citation_count":71,"is_preprint":false},{"pmid":"10329597","id":"PMC_10329597","title":"Characterization of the interleukin-1beta-converting enzyme/ced-3-family protease, caspase-3/CPP32, in Hodgkin's disease: lack of caspase-3 expression in nodular lymphocyte predominance Hodgkin's disease.","date":"1999","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/10329597","citation_count":70,"is_preprint":false},{"pmid":"9870561","id":"PMC_9870561","title":"Crucial role of apopain in the peroxynitrite-induced apoptotic DNA fragmentation.","date":"1998","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/9870561","citation_count":69,"is_preprint":false},{"pmid":"9202418","id":"PMC_9202418","title":"The apoptotic cysteine protease CPP32.","date":"1997","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/9202418","citation_count":67,"is_preprint":false},{"pmid":"8619857","id":"PMC_8619857","title":"Bcl-2 overexpression blocks activation of the death protease CPP32/Yama/apopain.","date":"1996","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/8619857","citation_count":66,"is_preprint":false},{"pmid":"21160486","id":"PMC_21160486","title":"CASP3 gene single-nucleotide polymorphism (rs72689236) and Kawasaki disease in Taiwanese children.","date":"2010","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21160486","citation_count":66,"is_preprint":false},{"pmid":"10379822","id":"PMC_10379822","title":"Postnatal distribution of cpp32/caspase 3 mRNA in the mouse central nervous system: an in situ hybridization study.","date":"1999","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/10379822","citation_count":66,"is_preprint":false},{"pmid":"8647264","id":"PMC_8647264","title":"Ligation of CD40 rescues Ramos-Burkitt lymphoma B cells from calcium ionophore- and antigen receptor-triggered apoptosis by inhibiting activation of the cysteine protease CPP32/Yama and cleavage of its substrate PARP.","date":"1996","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/8647264","citation_count":65,"is_preprint":false},{"pmid":"9467964","id":"PMC_9467964","title":"Involvement of CPP32/Caspase-3 in c-Myc-induced apoptosis.","date":"1998","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/9467964","citation_count":58,"is_preprint":false},{"pmid":"10928128","id":"PMC_10928128","title":"Reduced expression of ICE/caspase1 and CPP32/caspase3 in human hepatocellular carcinoma.","date":"2000","source":"Anticancer research","url":"https://pubmed.ncbi.nlm.nih.gov/10928128","citation_count":51,"is_preprint":false},{"pmid":"27765352","id":"PMC_27765352","title":"Dioscin suppresses hepatocellular carcinoma tumor growth by inducing apoptosis and regulation of TP53, BAX, BCL2 and cleaved CASP3.","date":"2016","source":"Phytomedicine : international journal of phytotherapy and phytopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/27765352","citation_count":51,"is_preprint":false},{"pmid":"10357879","id":"PMC_10357879","title":"Modulation of nitric oxide-induced apoptotic death of HL-60 cells by protein kinase C and protein kinase A through mitogen-activated protein kinases and CPP32-like protease pathways.","date":"1999","source":"Cellular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/10357879","citation_count":51,"is_preprint":false},{"pmid":"9455811","id":"PMC_9455811","title":"Resistance to apoptosis correlates with a highly proliferative phenotype and loss of Fas and CPP32 (caspase-3) expression in human leukemia cells.","date":"1998","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/9455811","citation_count":51,"is_preprint":false},{"pmid":"25929184","id":"PMC_25929184","title":"Increased expression and colocalization of GAP43 and CASP3 after brain ischemic lesion in mouse.","date":"2015","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/25929184","citation_count":50,"is_preprint":false},{"pmid":"9363747","id":"PMC_9363747","title":"Apoptotic cell death and caspase 3 (CPP32) activation induced by calcium ionophore at low concentrations and their prevention by nerve growth factor in PC12 cells.","date":"1997","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9363747","citation_count":44,"is_preprint":false},{"pmid":"18829519","id":"PMC_18829519","title":"CASP3 polymorphisms and risk of squamous cell carcinoma of the head and neck.","date":"2008","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/18829519","citation_count":43,"is_preprint":false},{"pmid":"8761296","id":"PMC_8761296","title":"Molecular characterization of mouse and rat CPP32 beta gene encoding a cysteine protease resembling interleukin-1 beta converting enzyme and CED-3.","date":"1996","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/8761296","citation_count":43,"is_preprint":false},{"pmid":"9733083","id":"PMC_9733083","title":"Apoptosis of undifferentiated progenitors and granule cell precursors in the postnatal human cerebellar cortex correlates with expression of BCL-2, ICE, and CPP32 proteins.","date":"1998","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/9733083","citation_count":41,"is_preprint":false},{"pmid":"8804412","id":"PMC_8804412","title":"CPP32/Yama/apopain cleaves the catalytic component of DNA-dependent protein kinase in the holoenzyme.","date":"1996","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/8804412","citation_count":38,"is_preprint":false},{"pmid":"10200474","id":"PMC_10200474","title":"Wortmannin enhances activation of CPP32 (Caspase-3) induced by TNF or anti-Fas.","date":"1998","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/10200474","citation_count":38,"is_preprint":false},{"pmid":"9873617","id":"PMC_9873617","title":"Conformationally constrained inhibitors of caspase-1 (interleukin-1 beta converting enzyme) and of the human CED-3 homologue caspase-3 (CPP32, apopain).","date":"1998","source":"Bioorganic & medicinal chemistry letters","url":"https://pubmed.ncbi.nlm.nih.gov/9873617","citation_count":38,"is_preprint":false},{"pmid":"31117242","id":"PMC_31117242","title":"MST1 Regulates Neuronal Cell Death via JNK/Casp3 Signaling Pathway in HFD Mouse Brain and HT22 Cells.","date":"2019","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31117242","citation_count":37,"is_preprint":false},{"pmid":"33028983","id":"PMC_33028983","title":"Ursolic acid reduces hepatocellular apoptosis and alleviates alcohol-induced liver injury via irreversible inhibition of CASP3 in vivo.","date":"2020","source":"Acta pharmacologica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/33028983","citation_count":37,"is_preprint":false},{"pmid":"16465208","id":"PMC_16465208","title":"Bcl-2 prevents activation of CPP32 cysteine protease and cleavage of poly (ADP-ribose) polymerase and U1-70 kD proteins in staurosporine-mediated apoptosis.","date":"1997","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/16465208","citation_count":36,"is_preprint":false},{"pmid":"23894522","id":"PMC_23894522","title":"A replication study for association of ITPKC and CASP3 two-locus analysis in IVIG unresponsiveness and coronary artery lesion in Kawasaki disease.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23894522","citation_count":36,"is_preprint":false},{"pmid":"9070923","id":"PMC_9070923","title":"Identification and mapping of Casp7, a cysteine protease resembling CPP32 beta, interleukin-1 beta converting enzyme, and CED-3.","date":"1997","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/9070923","citation_count":35,"is_preprint":false},{"pmid":"9235961","id":"PMC_9235961","title":"The large subunit of the DNA replication complex C (DSEB/RF-C140) cleaved and inactivated by caspase-3 (CPP32/YAMA) during Fas-induced apoptosis.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9235961","citation_count":34,"is_preprint":false},{"pmid":"9223451","id":"PMC_9223451","title":"Interleukin-1beta-converting enzyme and CPP32 are involved in ultraviolet B-induced apoptosis of SV40-transformed human keratinocytes.","date":"1997","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/9223451","citation_count":34,"is_preprint":false},{"pmid":"35573727","id":"PMC_35573727","title":"A Systematic Pan-Cancer Analysis of CASP3 as a Potential Target for Immunotherapy.","date":"2022","source":"Frontiers in molecular biosciences","url":"https://pubmed.ncbi.nlm.nih.gov/35573727","citation_count":32,"is_preprint":false},{"pmid":"9070890","id":"PMC_9070890","title":"Specific expression of CPP32 in sensory neurons of mouse embryos and activation of CPP32 in the apoptosis induced by a withdrawal of NGF.","date":"1997","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/9070890","citation_count":32,"is_preprint":false},{"pmid":"23271051","id":"PMC_23271051","title":"A functional variant at the miR-885-5p binding site of CASP3 confers risk of both index and second primary malignancies in patients with head and neck cancer.","date":"2012","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/23271051","citation_count":32,"is_preprint":false},{"pmid":"10200566","id":"PMC_10200566","title":"Inhibition of transforming growth factor beta1-induced hepatoma cell apoptosis by liver tumor promoters: characterization of primary signaling events and effects on CPP32-like caspase activity.","date":"1999","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/10200566","citation_count":31,"is_preprint":false},{"pmid":"9310497","id":"PMC_9310497","title":"Immunohistochemical analysis of interleukin-1beta-converting enzyme/Ced-3 family protease, CPP32/Yama/Caspase-3, in Hodgkin's disease.","date":"1997","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/9310497","citation_count":30,"is_preprint":false},{"pmid":"9720729","id":"PMC_9720729","title":"Vinorelbine induces apoptosis and caspase-3 (CPP32) expression in leukemia and lymphoma cells: a comparison with vincristine.","date":"1998","source":"Leukemia & lymphoma","url":"https://pubmed.ncbi.nlm.nih.gov/9720729","citation_count":30,"is_preprint":false},{"pmid":"9459486","id":"PMC_9459486","title":"Apoptotic cell death and CPP32-like activation induced by thapsigargin and their prevention by nerve growth factor in PC12 cells.","date":"1998","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/9459486","citation_count":29,"is_preprint":false},{"pmid":"33370709","id":"PMC_33370709","title":"Dihydroartemisinin inhibits the tumorigenesis and invasion of gastric cancer by regulating STAT1/KDR/MMP9 and P53/BCL2L1/CASP3/7 pathways.","date":"2020","source":"Pathology, research and practice","url":"https://pubmed.ncbi.nlm.nih.gov/33370709","citation_count":27,"is_preprint":false},{"pmid":"10601800","id":"PMC_10601800","title":"Regulation of apoptosis reduction in the cisplatin-resistant A431 cell line by Bcl-2 and CPP32.","date":"2000","source":"Chemotherapy","url":"https://pubmed.ncbi.nlm.nih.gov/10601800","citation_count":27,"is_preprint":false},{"pmid":"29168599","id":"PMC_29168599","title":"HOXC13 promotes proliferation of esophageal squamous cell carcinoma via repressing transcription of CASP3.","date":"2017","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/29168599","citation_count":27,"is_preprint":false},{"pmid":"27429846","id":"PMC_27429846","title":"Oncogenic miR-137 contributes to cisplatin resistance via repressing CASP3 in lung adenocarcinoma.","date":"2016","source":"American journal of cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/27429846","citation_count":27,"is_preprint":false},{"pmid":"8950980","id":"PMC_8950980","title":"Interleukin-7 inhibits apoptosis of mouse malignant T-lymphoma cells by both suppressing the CPP32-like protease activation and inducing the Bcl-2 expression.","date":"1996","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/8950980","citation_count":26,"is_preprint":false},{"pmid":"11075989","id":"PMC_11075989","title":"The pattern of CPP32/caspase-3 expression reflects the biological behavior of the human pancreatic duct cell tumors.","date":"2000","source":"Pancreas","url":"https://pubmed.ncbi.nlm.nih.gov/11075989","citation_count":25,"is_preprint":false},{"pmid":"10769693","id":"PMC_10769693","title":"Enhancement of chemotherapeutic agents induced-apoptosis associated with activation of c-Jun N-terminal kinase 1 and caspase 3 (CPP32) in bax-transfected gastric cancer cells.","date":"2000","source":"Anticancer research","url":"https://pubmed.ncbi.nlm.nih.gov/10769693","citation_count":25,"is_preprint":false},{"pmid":"15829155","id":"PMC_15829155","title":"Insulin-like growth factor-I decreased etoposide-induced apoptosis in glioma cells by increasing bcl-2 expression and decreasing CPP32 activity.","date":"2005","source":"Neurological research","url":"https://pubmed.ncbi.nlm.nih.gov/15829155","citation_count":24,"is_preprint":false},{"pmid":"10989191","id":"PMC_10989191","title":"Expression and activation of caspase-3/CPP32 in CD34(+) cord blood cells is linked to apoptosis after growth factor withdrawal.","date":"2000","source":"Experimental hematology","url":"https://pubmed.ncbi.nlm.nih.gov/10989191","citation_count":23,"is_preprint":false},{"pmid":"10403522","id":"PMC_10403522","title":"Specific dual effect of cycloheximide on B lymphocyte apoptosis: involvement of CPP32/caspase-3.","date":"1999","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/10403522","citation_count":22,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":51766,"output_tokens":7870,"usd":0.136674,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":17249,"output_tokens":4541,"usd":0.099885,"stage2_stop_reason":"end_turn"},"total_usd":0.236559,"stage1_batch_id":"msgbatch_01ACAxJQabDsht39JXeWG22d","stage2_batch_id":"msgbatch_01QEU22A9U5sbPTgsMzTmvSf","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1994,\n      \"finding\": \"CPP32 (CASP3) encodes a 32-kDa cysteine protease; overexpression in Sf9 insect cells induces apoptosis, and co-expression of recombinant p20 and p11 subunits (derived from the full-length sequence) reconstitutes apoptotic activity, establishing that CPP32 is processed into a two-subunit active complex.\",\n      \"method\": \"Cloning, overexpression in Sf9 cells, co-expression of recombinant subunits\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstitution of active enzyme from recombinant subunits with functional (apoptotic) readout; foundational cloning paper replicated by multiple subsequent studies\",\n      \"pmids\": [\"7983002\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Purified Yama/CPP32 (CASP3) zymogen, when activated, cleaves PARP to generate the 85-kDa apoptotic fragment; this cleavage is inhibited by CrmA but not by an inactive CrmA point mutant, and CrmA blocks PARP cleavage in apoptotic cells.\",\n      \"method\": \"In vitro protease assay with purified recombinant protein, inhibitor mutagenesis (CrmA point mutant), cell-based PARP cleavage assay\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — purified enzyme assay with substrate cleavage, mutant inhibitor controls, replicated across labs\",\n      \"pmids\": [\"7774019\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"The three-dimensional crystal structure of CPP32/apopain complexed with a tetrapeptide-aldehyde inhibitor was determined; the S4 subsite is strikingly different in size and chemical composition from ICE, explaining the distinct substrate specificity of CED-3-related versus ICE-related proteases.\",\n      \"method\": \"X-ray crystallography of inhibitor-bound complex\",\n      \"journal\": \"Nature structural biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure with functional interpretation of substrate-binding differences; single rigorous structural study\",\n      \"pmids\": [\"8673606\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Granzyme B, secreted by cytotoxic T lymphocytes, cleaves and activates the CPP32 precursor, providing a mechanistic link between CTL-mediated killing and activation of the CPP32/PARP cleavage pathway.\",\n      \"method\": \"In vitro cleavage assay: granzyme B incubated with CPP32 precursor; PARP cleavage as functional readout\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution of cleavage and activation; replicated independently by at least three additional groups (PMIDs 8700869, 8665848, 8702964)\",\n      \"pmids\": [\"7566124\", \"8700869\", \"8665848\", \"8702964\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Granzyme B directly cleaves CPP32 between its large and small subunits, generating an active protease; the prodomain is then removed by an autocatalytic step (two-step mechanism). CrmA inhibits granzyme B-mediated CPP32 processing and apoptosis.\",\n      \"method\": \"Cell-free extract reconstitution, inhibitor studies (tetrapeptide CPP32 inhibitor vs. ICE inhibitor), CrmA co-expression\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — cell-free reconstitution plus inhibitor dissection; mechanistic details confirmed by independent groups\",\n      \"pmids\": [\"8665848\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Granzyme B directly activates purified Yama/CPP32 by limited proteolysis; activated Yama can bind inhibitors and cleave PARP. Processing of ICE by granzyme B does not activate ICE, demonstrating substrate selectivity.\",\n      \"method\": \"In vitro protease assay with purified proteins; PARP cleavage and inhibitor-binding as functional readouts\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — purified protein reconstitution with specificity controls (ICE vs. Yama); replicated\",\n      \"pmids\": [\"8700869\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Granzyme B from granzyme B-deficient mouse cytolytic cells fails to cleave and activate CPP32 and fails to induce DNA fragmentation in target cells, confirming a non-redundant role for granzyme B in CPP32 activation and downstream DNA fragmentation.\",\n      \"method\": \"Granzyme B knockout cells, peptide inhibitor of CPP32-like proteases, 51Cr release assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic loss-of-function (granzyme B KO) with specific functional readout; replicated concept\",\n      \"pmids\": [\"8702964\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"CPP32/apopain cleaves U1-70 kDa snRNP protein and the catalytic subunit of DNA-dependent protein kinase (DNA-PKcs) at DEVD-like sites in vitro and in apoptotic cells, with fragments identical to those seen in intact apoptotic cells; cleavage is abolished by nanomolar Ac-DEVD-CHO.\",\n      \"method\": \"In vitro protease assay with purified apopain and isolated substrates; comparison of in vitro and in vivo cleavage fragments; inhibitor studies\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — purified enzyme assay, fragment identity confirmed, inhibitor specificity; replicated independently\",\n      \"pmids\": [\"8642305\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"CPP32 cleaves SREBP-1 and SREBP-2 at an aspartate residue during apoptosis, liberating transcriptionally active N-terminal fragments; an Asp→Ala mutation at the CPP32 cleavage site abolishes apoptosis-induced (but not sterol-regulated) SREBP cleavage.\",\n      \"method\": \"In vitro cleavage assay with purified CPP32; site-directed mutagenesis of the cleavage site; cell-based apoptosis assays (staurosporine, anti-Fas, etoposide)\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro enzyme assay plus site-directed mutagenesis of cleavage site confirming specificity\",\n      \"pmids\": [\"8605870\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"CPP32 processes pro-Mch6 (caspase-9) and pro-Mch2alpha (caspase-6, the lamin-cleaving enzyme) in vitro, activating them; site-directed mutagenesis identified specific aspartate processing sites. Granzyme B activates CPP32 which then activates Mch2alpha, establishing a protease cascade: granzyme B → CPP32 → Mch2alpha/Mch6.\",\n      \"method\": \"In vitro protease assay with purified recombinant enzymes; site-directed mutagenesis of processing sites; co-incubation with cellular extracts\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution with mutagenesis; cascade demonstrated with purified components\",\n      \"pmids\": [\"8900201\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"CPP32/apopain cleaves actin in vitro to 15- and 31-kDa fragments; a selective CPP32 inhibitor (Z-EVD-CH2-DCB) blocks actin cleavage and apoptosis in VP-16-treated U937 cells, and actin cleavage occurs in vivo during apoptosis.\",\n      \"method\": \"In vitro cleavage assay; antibody against cleavage-site neoepitope; selective caspase-3 inhibitor; cell-based apoptosis assay\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro enzyme assay plus neoepitope antibody confirming in vivo cleavage; inhibitor validation\",\n      \"pmids\": [\"9070648\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"D4-GDI (a GDP dissociation inhibitor for Rho family GTPases) is cleaved by recombinant CPP32 in vitro at DELD19↓S; this cleavage also occurs in Jurkat cells undergoing Fas- or staurosporine-induced apoptosis and is blocked by DEVD-CHO but not by YVAD-CHO.\",\n      \"method\": \"In vitro cleavage assay with recombinant E. coli-expressed CPP32; N-terminal sequencing of cleavage fragment; cell-based inhibitor studies\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — purified enzyme cleavage with N-terminal sequencing of product; inhibitor specificity confirmed\",\n      \"pmids\": [\"8626669\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"CPP32/Yama/apopain cleaves the catalytic subunit (p460) of DNA-PK in vitro, generating 230- and 160-kDa fragments and abolishing DNA-PK activity; cleavage is blocked by a selective CPP32 inhibitor but not by other protease inhibitors.\",\n      \"method\": \"In vitro cleavage assay with purified DNA-PK; kinase activity assay; selective inhibitor studies; cell-based apoptosis model\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro enzyme assay with functional (kinase) readout; confirmed by independent group (PMID 8798786)\",\n      \"pmids\": [\"8804412\", \"8798786\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Huntingtin is cleaved specifically by apopain (CPP32) in apoptotic extracts and by purified apopain; the rate of cleavage increases with polyglutamine tract length.\",\n      \"method\": \"In vitro cleavage assay with purified apopain and recombinant huntingtin variants; apoptotic cell extract cleavage assay\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution with substrate length variant series; mechanistically specific finding\",\n      \"pmids\": [\"8696339\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Fas-induced apoptosis sequentially activates ICE-like proteases followed by CPP32-like proteases; CPP32 activity accumulates in the cytosol in an ICE-dependent manner, and supplementing cell lysates from ICE-null thymocytes with recombinant CPP32 reconstitutes nuclear apoptosis.\",\n      \"method\": \"Cell-free apoptosis system; specific inhibitors of ICE- vs. CPP32-like proteases; ICE-null mouse thymocytes; recombinant CPP32 reconstitution\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — genetic (ICE KO) and biochemical reconstitution with defined inhibitors; epistasis established\",\n      \"pmids\": [\"8614469\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"An ICE-family protease (CAP/Mch2alpha homolog) purified from hamster cells cleaves and activates CPP32 in vitro; CAP activity is inhibited by CrmA and is itself activated by proteolytic cleavage, consistent with a cascade upstream of CPP32.\",\n      \"method\": \"Protein purification, in vitro CPP32 activation assay, protein sequencing, inhibitor studies\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — purified upstream activating protease identified by sequencing; in vitro activation of CPP32 reconstituted\",\n      \"pmids\": [\"8662833\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"CPP32 proenzyme is proteolytically processed and activated in Fas-ligated Jurkat cells; CPP32 activation is blocked by cell-permeable inhibitors of aspartate-directed cysteine proteases and by overexpression of Bcl-2, placing Bcl-2 at or upstream of the CPP32 activation step.\",\n      \"method\": \"Western blot for CPP32 processing, cell-permeable inhibitors, Bcl-2 overexpression, cell viability assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — CPP32 processing monitored by Western blot; Bcl-2 overexpression epistasis; replicated by multiple groups\",\n      \"pmids\": [\"8663439\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Bcl-2 overexpression prevents CPP32 maturation (zymogen cleavage) and PARP cleavage in TNFα-induced apoptosis of U937 monocytes; no physical interaction between Bcl-2 and CPP32 was detected, indicating the inhibitory effect is indirect.\",\n      \"method\": \"Western blot for CPP32 processing; PARP cleavage assay; co-immunoprecipitation (negative result for physical interaction); Bcl-2 overexpression\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Western blot epistasis, negative Co-IP result mechanistically informative; single lab\",\n      \"pmids\": [\"8619857\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"CPP32-like protease activity is activated in Fas-induced apoptosis of Jurkat T cells; the activity has kinetics similar to purified apopain, cleaves PARP, is recognized by anti-CPP32 antibodies but not anti-ICE antibodies, and a selective apopain inhibitor prevents Fas-induced apoptosis.\",\n      \"method\": \"Biochemical isolation of protease from apoptotic cells; kinetic analysis; substrate cleavage; antibody recognition; selective inhibitor\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal biochemical methods; replicated across labs\",\n      \"pmids\": [\"8567626\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"CPP32 (caspase-3) cleaves p21-activated kinase gamma-PAK (Pak2) in vitro into two fragments (residues 1-212 and 213-524); subsequent autophosphorylation of both cleavage products occurs, and activation of the catalytic domain requires autophosphorylation at Thr-402 (mutation Thr402Ala abolishes activity).\",\n      \"method\": \"In vitro CPP32 cleavage assay with recombinant gamma-PAK; autophosphorylation assay; site-directed mutagenesis (Thr402Ala)\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution with mutagenesis; two-step activation mechanism defined\",\n      \"pmids\": [\"9786869\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"The large subunit of DNA replication factor DSEB/RF-C140 is cleaved by caspase-3 at DEVD706/G during Fas-induced apoptosis in Jurkat cells; Asp706→Ala mutation abolishes cleavage in vitro; cleavage is inhibited by Ac-DEVD-CHO and iodoacetamide but not by CrmA or Ac-YVAD-CHO; recombinant caspase-3 (but not caspase-1) reproduces the in vivo cleavage.\",\n      \"method\": \"In vitro translated substrate cleavage assay; site-directed mutagenesis of cleavage site; selective caspase inhibitors; recombinant caspase-3 reconstitution\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — mutagenesis of cleavage site, reconstitution with pure enzyme, inhibitor specificity\",\n      \"pmids\": [\"9235961\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"CPP32-deficient (knockout) mice display profoundly defective neuronal apoptosis during brain development, including absence of pyknotic clusters at morphogenetic sites and hyperplasias, establishing that CPP32 is essential for morphogenetic cell death in the mammalian brain in vivo.\",\n      \"method\": \"Homologous recombination knockout; histological analysis; embryonic brain phenotyping\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — germline KO with specific developmental phenotype; foundational loss-of-function study replicated by independent group (PMID 9512515)\",\n      \"pmids\": [\"8934524\", \"9512515\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"CPP32 (caspase-3) is required for chromatin condensation and DNA degradation in certain apoptotic cell types, but other hallmarks of apoptosis can proceed in its absence; the requirement is stimulus- and tissue-specific (e.g., required for UV- but not γ-irradiation-induced apoptosis in ES cells; required for TNFα-induced apoptosis in transformed MEFs but not thymocytes).\",\n      \"method\": \"Comprehensive analysis of CPP32-deficient mice, ES cells, and MEFs with multiple apoptotic stimuli; DNA fragmentation, chromatin condensation assays\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal cell types and stimuli in KO background; systematic loss-of-function study\",\n      \"pmids\": [\"9512515\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"C. elegans CED-3 cysteine protease has substrate specificity similar to CPP32 (both prefer DEVD-like sites), distinct from ICE or NEDD2/ICH-1, supporting CPP32 as the mammalian functional equivalent of CED-3.\",\n      \"method\": \"Purification of CED-3 and four ICE-family proteases; direct comparative substrate specificity assays\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — purified enzymes compared with defined substrates; ortholog relationship established biochemically\",\n      \"pmids\": [\"8654923\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Active CPP32 (caspase-3) is the major active caspase in apoptotic tumor cells across multiple stimuli and cell lines; CPP32 is present as multiple active species whose pattern varies between cell lines but is constant across stimuli within a given line, indicating cell-line-specific processing differences.\",\n      \"method\": \"Novel active-caspase detection approach (affinity labeling); multiple tumor cell lines and apoptotic stimuli; CPP32 and Mch2 identified simultaneously\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — active-site labeling across multiple cell lines and stimuli; systematic identification of major active caspase species\",\n      \"pmids\": [\"9171342\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"CPP32 activation during Fas-induced apoptosis requires macromolecular synthesis and upstream CED3/ICE protease activity; affinity labeling of the active-site cysteine identified p20/p18 processed subunits in apoptotic but not necrotic granule neurons, with CPP32 activation preceding PARP cleavage and DNA laddering.\",\n      \"method\": \"Active-site affinity labeling; RNA and protein synthesis inhibitors; CED3/ICE inhibitor pretreatment; temporal Western blot analysis\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — active-site labeling plus inhibitor epistasis; single lab but multiple orthogonal methods\",\n      \"pmids\": [\"8987778\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Fas-induced activation of JNK/SAPK (via MKK7) and p38 (via MKK6), cell shrinkage, surface blebbing, Apo2.7 antigen induction, and cell death all occur independently of CPP32-like protease activity; CPP32-like proteases are specifically required for chromatin condensation and DNA fragmentation but not for other Fas-induced apoptotic events.\",\n      \"method\": \"Selective caspase inhibitors (DEVD-type vs. VAD-type) in Jurkat and KB cells; kinase activation assays; morphological and cell death assessments\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — pharmacological epistasis with highly selective inhibitors; multiple orthogonal readouts; clearly defined pathway bifurcation\",\n      \"pmids\": [\"9362518\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"During T-cell negative selection in vivo, CPP32 activation (detected by proteolytic cleavage of p32 zymogen) occurs specifically upon anti-CD3 crosslinking or antigen challenge (pigeon cytochrome C in MHC-compatible mice) and precedes phosphatidylserine exposure; it is not detected during spontaneous thymocyte apoptosis, suggesting a distinct pathway for activation-induced cell death.\",\n      \"method\": \"Western blot for CPP32 processing; PARP cleavage; in vivo antigen challenge of TCR-transgenic mice; caspase inhibitor (zVAD) studies\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo antigen challenge with transgenic mice plus biochemical readouts; single lab\",\n      \"pmids\": [\"9348308\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Thyroid hormone up-regulates Xenopus CPP32/apopain/Yama gene expression in a tadpole tail myoblast cell line (XLT-15), and a CPP32/apopain inhibitor (Ac-DEVD-CHO) prevents thyroid hormone-induced apoptosis, while an ICE inhibitor does not, establishing that CPP32 mediates thyroid hormone-dependent apoptosis in this model.\",\n      \"method\": \"RT-PCR for CPP32 mRNA; TUNEL assay; selective inhibitor (DEVD-CHO vs. YVAD-CHO); cell viability\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — selective inhibitor dissects CPP32 vs. ICE; single lab with two orthogonal readouts (mRNA induction + inhibitor rescue)\",\n      \"pmids\": [\"9030578\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"MST1 kinase activates JNK which in turn activates caspase-3 (Casp3) in a signaling cascade mediating neuronal apoptosis in high-fat diet mouse brain and HT22 cells; shRNA knockdown of MST1 significantly reduces JNK/Casp3 signaling.\",\n      \"method\": \"Western blot; immunofluorescence; shRNA knockdown of MST1; in vivo HFD mouse model\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function (shRNA) with Western blot confirmation; in vivo and in vitro; single lab\",\n      \"pmids\": [\"31117242\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Caspase-2 (Nedd-2) processing and cell death in trophic factor-deprived PC12 cells and sympathetic neurons occur independently of caspase-3 (CPP32)-like activity; DEVD-FMK inhibits caspase-3-like activity but does not suppress caspase-2 processing or cell death; caspase-3-like activity is neither necessary nor sufficient for death in this paradigm.\",\n      \"method\": \"Selective caspase inhibitors (DEVD-FMK vs. BAF/zVAD-FMK); caspase-2 antisense oligonucleotide; Western blot for caspase-2 processing; cell survival assays\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — inhibitor and antisense epistasis; single lab; finding is a negative result for CPP32 requirement that is itself mechanistically informative\",\n      \"pmids\": [\"9801360\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Ursolic acid (UA) metabolite irreversibly inhibits CASP3 by forming a covalent bond with Cys-163 of caspase-3 via an epoxy group; an alkynyl-modified UA probe captured CASP3 as the primary target from mouse liver, and binding was verified by molecular docking, biochemical evaluation in HepG2 cells, and in vivo liver injury attenuation.\",\n      \"method\": \"Chemical probe (alkynyl-modified UA) pulldown/proteome identification; molecular docking to active-site Cys-163; biochemical CASP3 activity assay; in vivo alcoholic liver disease model\",\n      \"journal\": \"Acta pharmacologica Sinica\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — chemical probe target identification plus docking and biochemical validation; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"33028983\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"HOXC13 represses transcription of CASP3 by directly binding to the CASP3 promoter region (ChIP analysis); knockdown of HOXC13 in esophageal squamous cell carcinoma cells upregulates CASP3 and induces apoptosis.\",\n      \"method\": \"ChIP analysis; HOXC13 knockdown; RT-PCR and Western blot for CASP3; apoptosis assay\",\n      \"journal\": \"Cancer science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP establishes direct promoter binding; loss-of-function with functional readout; single lab\",\n      \"pmids\": [\"29168599\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CASP3/CPP32 (caspase-3) is synthesized as a 32-kDa inactive zymogen that is proteolytically activated by upstream ICE-family proteases or by granzyme B (which cleaves between the large and small subunits, followed by autocatalytic prodomain removal) to yield an active p20/p11 heterodimeric cysteine protease; the activated enzyme cleaves a defined set of substrates at DEVD-like sites—including PARP, DNA-PKcs, DSEB/RF-C140, SREBPs, huntingtin, D4-GDI, actin, lamin-associated Mch2alpha, and Pak2—to dismantle nuclear repair, DNA replication, cytoskeletal, and signaling functions; its S4 substrate-binding pocket is structurally distinct from ICE, conferring DEVD specificity; Bcl-2/Bcl-xL act upstream to prevent CPP32 activation without direct physical interaction; CPP32 is essential for chromatin condensation, DNA fragmentation, and morphogenetic brain apoptosis in vivo, but other apoptotic events (JNK/p38 activation, membrane blebbing, cell death itself) can proceed independently of CPP32-like activity in certain contexts.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"CASP3 (CPP32/Yama/apopain) is the principal executioner cysteine protease of apoptosis, synthesized as a 32-kDa zymogen that is proteolytically processed into a two-subunit (p20/p11) active enzyme [#0]. Its crystal structure bound to a tetrapeptide-aldehyde inhibitor revealed an S4 subsite distinct from ICE, accounting for its preference for DEVD-like cleavage sites [#2], a specificity that mirrors C. elegans CED-3 and marks CASP3 as the mammalian functional equivalent of that death protease [#23]. CASP3 is activated by limited proteolysis at the junction between its large and small subunits, either by cytotoxic-lymphocyte granzyme B followed by autocatalytic prodomain removal [#3, #4, #5] or by upstream ICE/CED3-family proteases, placing it downstream in a sequential caspase cascade during Fas-induced death [#14, #15]. Once active, CASP3 cleaves a defined substrate set at DEVD-like sites to dismantle the cell: PARP [#1], the DNA-PKcs catalytic subunit [#7, #12], DNA replication factor DSEB/RF-C140 [#20], U1-70K snRNP [#7], SREBP-1/2 [#8], huntingtin [#13], the Rho-GTPase regulator D4-GDI [#11], actin [#10], and the kinase Pak2 [#19]; it also amplifies the cascade by processing and activating pro-caspase-9 (Mch6) and the lamin-cleaving caspase-6 (Mch2alpha) [#9]. CASP3 is itself held in check upstream by Bcl-2, which blocks zymogen maturation without physically binding the enzyme [#16, #17]. Genetic ablation establishes that CASP3 is essential for morphogenetic neuronal apoptosis in the developing brain [#21] and for chromatin condensation and DNA fragmentation, although membrane blebbing, JNK/p38 activation and cell death itself can proceed independently of CASP3 activity in a stimulus- and tissue-specific manner [#22, #26].\",\n  \"teleology\": [\n    {\n      \"year\": 1994,\n      \"claim\": \"Established the molecular identity of CASP3 as a 32-kDa cysteine protease whose proteolytic processing into two subunits is required for pro-apoptotic activity.\",\n      \"evidence\": \"Cloning and Sf9 overexpression with reconstitution from recombinant p20/p11 subunits\",\n      \"pmids\": [\"7983002\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify the physiological protease(s) that perform the activating cleavage\", \"No substrate repertoire defined at this stage\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Defined the first executioner function by showing CASP3 cleaves PARP to its apoptotic signature fragment, linking the protease to a specific nuclear substrate.\",\n      \"evidence\": \"In vitro protease assay with purified enzyme; CrmA wild-type vs. inactive mutant controls; cell-based PARP cleavage\",\n      \"pmids\": [\"7774019\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not establish whether PARP cleavage is causal for death or a bystander event\", \"Upstream activator still unknown\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Identified granzyme B as a physiological activator, connecting CTL-mediated killing to the CASP3/PARP pathway.\",\n      \"evidence\": \"In vitro cleavage of CPP32 precursor by granzyme B with PARP cleavage readout; independently replicated\",\n      \"pmids\": [\"7566124\", \"8700869\", \"8665848\", \"8702964\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Granzyme-independent activation routes not yet defined here\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Resolved the activation mechanism and its specificity: granzyme B cleaves between large and small subunits followed by autocatalytic prodomain removal, and does not activate ICE.\",\n      \"evidence\": \"Cell-free reconstitution, purified-protein cleavage, inhibitor dissection (CPP32 vs. ICE inhibitors), CrmA; KO granzyme B cells confirm non-redundancy\",\n      \"pmids\": [\"8665848\", \"8700869\", \"8702964\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of subunit-junction recognition by granzyme B not defined\", \"Relative contribution of autocatalysis vs. trans-cleavage in cells unquantified\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Provided the structural explanation for DEVD specificity, distinguishing CED-3-like from ICE-like proteases.\",\n      \"evidence\": \"X-ray crystallography of inhibitor-bound CPP32/apopain; comparative analysis of the S4 subsite\",\n      \"pmids\": [\"8673606\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structure of the apo or fully zymogenic form\", \"Does not capture substrate-induced conformational changes\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Placed CASP3 within a sequential protease cascade downstream of ICE-like enzymes and showed it both receives and propagates activation.\",\n      \"evidence\": \"Cell-free Fas system, ICE-null thymocyte reconstitution with recombinant CASP3, purified upstream activating protease (CAP/Mch2alpha homolog); CASP3 activation of pro-caspase-9 and caspase-6\",\n      \"pmids\": [\"8614469\", \"8662833\", \"8900201\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The full set of physiological upstream initiators was not enumerated\", \"Quantitative hierarchy of cascade branches in vivo unresolved\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Mapped a broad DEVD-site substrate repertoire, explaining how CASP3 dismantles nuclear, replication, cytoskeletal, and signaling machinery.\",\n      \"evidence\": \"In vitro cleavage of DNA-PKcs, U1-70K, SREBP-1/2, huntingtin, D4-GDI, actin (with neoepitope antibodies, N-terminal sequencing, cleavage-site mutagenesis) plus matched in vivo apoptotic fragments and inhibitor specificity\",\n      \"pmids\": [\"8642305\", \"8804412\", \"8798786\", \"8605870\", \"8696339\", \"8626669\", \"9070648\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not establish which cleavages are necessary vs. dispensable for the death phenotype\", \"Order and kinetics of substrate processing in cells not fully ordered\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Positioned Bcl-2 as an upstream, indirect inhibitor acting at the CASP3 maturation step rather than by binding the protease.\",\n      \"evidence\": \"Western blot for zymogen processing under Bcl-2 overexpression; negative co-immunoprecipitation for physical interaction\",\n      \"pmids\": [\"8663439\", \"8619857\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Negative Co-IP does not define the actual molecular intermediary blocked by Bcl-2\", \"Single-lab for the indirect-mechanism conclusion\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Established CASP3 as the major active executioner caspase across diverse apoptotic stimuli, with cell-line-specific processed species.\",\n      \"evidence\": \"Active-site affinity labeling across multiple tumor lines and stimuli\",\n      \"pmids\": [\"9171342\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional meaning of distinct processed species between lines not resolved\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Demonstrated in vivo non-redundancy: CASP3 is essential for morphogenetic neuronal apoptosis in the developing brain.\",\n      \"evidence\": \"Germline knockout mice with histological brain phenotyping; independently replicated\",\n      \"pmids\": [\"8934524\", \"9512515\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Tissue-specific substrate dependencies underlying the brain phenotype not dissected\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Delimited CASP3's functional scope: required for chromatin condensation and DNA fragmentation but dispensable for other apoptotic hallmarks, in a stimulus- and tissue-specific manner.\",\n      \"evidence\": \"Comprehensive KO mouse/ES cell/MEF analysis with multiple stimuli; selective DEVD vs. VAD inhibitor epistasis with morphological and kinase readouts\",\n      \"pmids\": [\"9512515\", \"9362518\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the redundant caspases substituting in CASP3-null cells not established here\", \"Mechanism of stimulus-specific requirement unresolved\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Refined pathway boundaries by showing CASP3-like activity is neither necessary nor sufficient for death in trophic-factor-deprived neurons, where caspase-2 acts independently.\",\n      \"evidence\": \"Selective inhibitor (DEVD-FMK vs. BAF) and caspase-2 antisense epistasis in PC12 cells and sympathetic neurons\",\n      \"pmids\": [\"9801360\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab pharmacological/antisense dissection\", \"Does not exclude partial CASP3 contribution masked by redundancy\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Added an upstream signaling input by placing CASP3 downstream of an MST1\\u2192JNK cascade in diet-associated neuronal apoptosis.\",\n      \"evidence\": \"shRNA knockdown of MST1 with Western/immunofluorescence in HFD mouse brain and HT22 cells\",\n      \"pmids\": [\"31117242\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab correlational signaling pathway\", \"Direct vs. indirect link between JNK and CASP3 activation not biochemically resolved\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Defined a pharmacological handle on the active-site cysteine, identifying CASP3 Cys-163 as a covalent target for an irreversible small-molecule inhibitor.\",\n      \"evidence\": \"Alkynyl-modified ursolic acid probe pulldown/proteome ID, molecular docking to Cys-163, biochemical activity assay, in vivo liver injury model\",\n      \"pmids\": [\"33028983\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Selectivity versus other caspases not fully quantified\", \"Single-lab target identification\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Identified transcriptional regulation of CASP3 by HOXC13 as a route controlling apoptotic threshold in cancer cells.\",\n      \"evidence\": \"ChIP showing direct promoter binding; HOXC13 knockdown with CASP3 induction and apoptosis readout in esophageal squamous carcinoma cells\",\n      \"pmids\": [\"29168599\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab; generality across tissues unknown\", \"Does not link transcriptional control to specific physiological death programs\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How CASP3 substrate cleavage choices are prioritized in vivo and which cleavages are causally required for the death phenotype versus tissue-redundant remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No systematic mapping of which substrate cleavages are necessary vs. dispensable for death\", \"Identity of caspases redundant with CASP3 in null tissues not defined in this corpus\", \"Structural basis of zymogen-to-active transition not captured\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 1, 7, 8, 9, 10, 11, 12, 13, 19, 20]},\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [0, 1, 2]},\n      {\"term_id\": \"GO:0008233\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [14]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [0, 21, 22, 26]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [3, 6, 27]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"GZMB\", \"BCL2\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}